ethyl pyruvate has been researched along with Hypertension, Pulmonary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, G; Li, J; Liu, C; Sun, H; Tang, M; Zhang, X | 1 |
| Cao, G; Fang, C; Li, S; Liu, C; Liu, K; Wan, Z; Wang, B; Wu, S | 1 |
| Cao, G; Liu, C; Liu, K; Liu, Y; Pang, X; Sun, H; Zhang, X | 1 |
3 other study(ies) available for ethyl pyruvate and Hypertension, Pulmonary
| Article | Year |
|---|---|
Ethyl Pyruvate Alleviates Pulmonary Hypertension through the Suppression of Pulmonary Artery Smooth Muscle Cell Proliferation via the High Mobility Group Protein B1/Receptor for Advanced Glycation End-Products Axis.
Topics: Animals; Cell Proliferation; HMGB1 Protein; Hypertension, Pulmonary; Myocytes, Smooth Muscle; Pulmonary Artery; Pyruvates; Rats; Receptor for Advanced Glycation End Products; Treatment Outcome | 2021 |
Ethyl pyruvate ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Drug Administration Schedule; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Hypertension, Pulmonary; Injections, Intraperitoneal; Interleukin-6; Male; Monocrotaline; Pyruvates; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2014 |
Intratracheal instillation of ethyl pyruvate nanoparticles prevents the development of shunt-flow-induced pulmonary arterial hypertension in a rat model.
Topics: Animals; Disease Models, Animal; Endothelin-1; Hypertension, Pulmonary; Interleukin-6; Lung; Male; Nanoparticles; Polyesters; Polyethylene Glycols; Protective Agents; Pulmonary Artery; Pyruvates; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Vascular Remodeling | 2016 |